Great Basin Scientific, Inc. (NASDAQ:GBSN) belonging to the Medical sector which declined -37.12% and closed its last trading session at $1.44.
The company reported its last EPS on 6/30/2016 and is expected to report its next EPS on NA. Currently, the stock has a 1 Year Price Target of $1575840.
The Company got Initiated by Dawson James on 27-May-15 to Buy.
Insider Trades for Great Basin Scientific, Inc. show that the latest trade was made on 30 Jan 2016 where Spafford (David), the Director completed a transaction type “Buy” in which 1908172 shares were traded at a price of $2.55.
Great Basin Scientific, Inc. (NASDAQ:GBSN) has the market capitalization of $1.2 Million. The company rocked its 52-Week High of $45024 on Nov 30, 2015 and touched its 52-Week Low of $1.42 on Sep 29, 2016. The stock has Return on Assets (ROA) of -241.4 percent. Return on Equity (ROE) stands at 162.9% and Return on Investment (ROI) of 121.8 percent.
The stock is currently showing YTD performance of -99.95 Percent. The company has Beta Value of 0 and ATR value of 1.34. The Weekly and Monthly Volatility stands at 32.78% and 30.20%.
Great Basin Scientific, Inc. is a molecular diagnostics company. It is focused on improving patient care through the development and commercialization of its patented, molecular diagnostic platform designed to test for infectious disease, especially hospital-acquired infections. Great Basin Scientific, Inc. is headquartered in Salt Lake City, Utah.